Hong X-w, Chi Z-p, Liu G-y, Huang H, Guo S-q, Fan J-r, et al. Characteristics of renal function in patients diagnosed with COVID-19: an observational study. Frontiers in Medicine. 2020;7: 409. https://doi.org/10.3389/fmed.2020.00409.
Article PubMed PubMed Central Google Scholar
Alimohamadi Y, Sepandi M, Taghdir M, Hosamirudsari H. Determine the most common clinical symptoms in COVID-19 patients: a systematic review and meta-analysis. Journal of preventive medicine and hygiene. 2020;61(3):E304. https://doi.org/10.15167/2421-4248/jpmh2020.61.3.1530.
Article PubMed PubMed Central Google Scholar
Pinto BG, Oliveira AE, Singh Y, Jimenez L, Gonçalves AN, Ogava RL, et al. ACE2 expression is increased in the lungs of patients with comorbidities associated with severe COVID-19. J Infect Dis. 2020;222(4):556–63. https://doi.org/10.1101/2020.03.21.20040261.
Article PubMed PubMed Central Google Scholar
Sanyaolu A, Okorie C, Marinkovic A, Patidar R, Younis K, Desai P, et al. Comorbidity and its impact on patients with COVID-19. SN comprehensive clinical medicine. 2020;2:1069–76. https://doi.org/10.1007/s42399-020-00363-4.
Article PubMed PubMed Central Google Scholar
Vetter P, Vu DL, L’Huillier AG, Schibler M, Kaiser L, Jacquerioz F. Clinical features of COVID-19. British medical journal publishing group; 2020. https://doi.org/10.1136/bmj.m1470
Hu Y, Sun J, Dai Z, Deng H, Li X, Huang Q, et al. Prevalence and severity of corona virus disease 2019 (COVID-19): a systematic review and meta-analysis. Journal of clinical virology. 2020;127: 104371. https://doi.org/10.1016/j.jcv.2020.104371.
Article PubMed PubMed Central Google Scholar
Guan W-j, Liang W-h, Zhao Y, Liang H-r, Chen Z-s, Li Y-m, et al. Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis. European Respiratory Journal. 2020;55(5):2000547. https://doi.org/10.1183/13993003.00547-2020.
Zhang J, Wu J, Sun X, Xue H, Shao J, Cai W, et al. Association of hypertension with the severity and fatality of SARS-CoV-2 infection: a meta-analysis. Epidemiology and Infection. 2020;148:148. https://doi.org/10.1017/S095026882000117X.
Petrilli CM, Jones SA, Yang J, Rajagopalan H, O’Donnell L, Chernyak Y, et al. Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease 2019 in New York City: prospective cohort study. bmj. 2020;369. https://doi.org/10.1136/bmj.m1966.
Williamson EJ, Walker AJ, Bhaskaran K, Bacon S, Bates C, Morton CE, et al. Factors associated with COVID-19-related death using OpenSAFELY. Nature. 2020;584(7821):430–6. https://doi.org/10.1038/s41586-020-2521-4.
Article PubMed PubMed Central Google Scholar
Ozturk S, Turgutalp K, Arici M, Odabas AR, Altiparmak MR, Aydin Z, et al. Mortality analysis of COVID-19 infection in chronic kidney disease, haemodialysis and renal transplant patients compared with patients without kidney disease: a nationwide analysis from Turkey. Nephrol Dial Transplant. 2020;35(12):2083–95. https://doi.org/10.1093/ndt/gfaa271.
Article PubMed PubMed Central Google Scholar
Soney H, DeRon N Jr, Wang L, Hoang L, Abualfoul M, Zhao Y, et al. Coronary artery disease as an independent predictor of cardiovascular mortality in COVID-19 patients. Cardiol Res. 2023;14(3):221. https://doi.org/10.14740/cr1471.
Article PubMed PubMed Central Google Scholar
Fried JA, Ramasubbu K, Bhatt R, Topkara VK, Clerkin KJ, Horn E, et al. The variety of cardiovascular presentations of COVID-19. Circulation. 2020;141(23):1930–6. https://doi.org/10.1161/CIRCULATIONAHA.120.047164.
Article PubMed PubMed Central Google Scholar
Bae S, Kim SR, Kim M-N, Shim WJ, Park S-M. Impact of cardiovascular disease and risk factors on fatal outcomes in patients with COVID-19 according to age: a systematic review and meta-analysis. Heart. 2021;107(5):373–80. https://doi.org/10.1136/heartjnl-2020-317901.
Group RC. Dexamethasone in hospitalized patients with Covid-19. N Engl J Med. 2021;384(8):693–704. https://doi.org/10.1056/NEJMoa2021436.
Li J-X, Cummins CL. Fresh insights into glucocorticoid-induced diabetes mellitus and new therapeutic directions. Nat Rev Endocrinol. 2022;18(9):540–57. https://doi.org/10.1038/s41574-022-00683-6.
Article PubMed PubMed Central Google Scholar
Khunti K, Del Prato S, Mathieu C, Kahn SE, Gabbay RA, Buse JB. COVID-19, hyperglycemia, and new-onset diabetes. Diabetes Care. 2021;44(12):2645–55. https://doi.org/10.2337/dc21-1318.
Article PubMed PubMed Central Google Scholar
Metwally AA, Mehta P, Johnson BS, Nagarjuna A, Snyder MP. COVID-19–induced new-onset diabetes: trends and technologies. Diabetes. 2021;70(12):2733–44. https://doi.org/10.2337/dbi21-0029.
Article PubMed PubMed Central Google Scholar
Rayman G, Lumb A, Kennon B, Cottrell C, Nagi D, Page E, et al. Dexamethasone therapy in COVID‐19 patients: implications and guidance for the management of blood glucose in people with and without diabetes. Diabet Medi. 2021;38(1). https://doi.org/10.1111/dme.14378.
Sproston NR, Ashworth JJ. Role of C-reactive protein at sites of inflammation and infection. Front Immunol. 2018;9: 754. https://doi.org/10.3389/fimmu.2018.00754.
Article PubMed PubMed Central Google Scholar
Clark R, Waters B, Stanfill AG. Elevated liver function tests in COVID-19: causes, clinical evidence, and potential treatments. Nurse Pract. 2021;46(1):21. https://doi.org/10.1097/01.NPR.0000722316.63824.f9.
Malik P, Patel U, Mehta D, Patel N, Kelkar R, Akrmah M, et al. Biomarkers and outcomes of COVID-19 hospitalisations: systematic review and meta-analysis. BMJ evidence-based medicine. 2021;26(3):107–8. https://doi.org/10.1136/bmjebm-2020-111536.
Ou M, Zhu J, Ji P, Li H, Zhong Z, Li B, et al. Risk factors of severe cases with COVID-19: a meta-analysis. Epidemiology and Infection. 2020;148: e175. https://doi.org/10.1017/S095026882000179X.
Cardinali DP, Hardeland R. Inflammaging, metabolic syndrome and melatonin: a call for treatment studies. Neuroendocrinology. 2017;104(4):382–97. https://doi.org/10.1159/000446543.
Hilser JR, Han Y, Biswas S, Gukasyan J, Cai Z, Zhu R, et al. Association of serum HDL-cholesterol and apolipoprotein A1 levels with risk of severe SARS-CoV-2 infection. J Lipid Res. 2021;62. https://doi.org/10.1016/j.jlr.2021.100061.
Masana L, Correig E, Ibarretxe D, Anoro E, Arroyo JA, Jericó C, et al. Low HDL and high triglycerides predict COVID-19 severity. Sci Rep. 2021;11(1):7217. https://doi.org/10.1038/s41598-021-86747-5.
Article PubMed PubMed Central Google Scholar
Zhang X-J, Qin J-J, Cheng X, Shen L, Zhao Y-C, Yuan Y, et al. In-hospital use of statins is associated with a reduced risk of mortality among individuals with COVID-19. Cell metabolism. 2020;32(2):176–87.e4. https://doi.org/10.1016/j.cmet.2020.06.015.
Article PubMed PubMed Central Google Scholar
Feingold KR. Lipid and lipoprotein levels in patients with COVID-19 infections. In: Feingold KR, Anawalt B, Boyce A, Chrousos G, de Herder WW, Dhatariya K, Dungan K, Grossman A, Hershman JM, Hofland J et al, editors. Endotext. South Dartmouth (MA): MDText.com, Inc. Copyright © 2000–2021, MDText.com, Inc.; 2020.
Tian S, Hu W, Niu L, Liu H, Xu H, Xiao S-Y. Pulmonary pathology of early-phase 2019 novel coronavirus (COVID-19) pneumonia in two patients with lung cancer. J Thorac Oncol. 2020;15(5):700–4. https://doi.org/10.1016/j.jtho.2020.02.010.
Article PubMed PubMed Central Google Scholar
Farhana A, Lappin SL. Biochemistry, lactate dehydrogenase StatPearls [Internet] StatPearls Publishing, 2020.
Han Y, Zhang H, Mu S, Wei W, Jin C, Tong C, et al. Lactate dehydrogenase, an independent risk factor of severe COVID-19 patients: a retrospective and observational study. Aging (Albany NY). 2020;12(12):11245. https://doi.org/10.18632/aging.103372.
Erez A, Shental O, Tchebiner JZ, Laufer-Perl M, Wasserman A, Sella T, et al. Diagnostic and prognostic value of very high serum lactate dehydrogenase in admitted medical patients. Isr Med Assoc J. 2014;16(7):439–43.
Icard P, Lincet H, Wu Z, Coquerel A, Forgez P, Alifano M, et al. The key role of Warburg effect in SARS-CoV-2 replication and associated inflammatory response. Biochimie. 2021;180:169–77. https://doi.org/10.1016/j.biochi.2020.11.010.
He Q, Mok TN, Yun L, He C, Li J, Pan J. Single-cell RNA sequencing analysis of human kidney reveals the presence of ACE2 receptor: a potential pathway of COVID-19 infection. Mol Genet Genomic Med. 2020;8(10): e1442. https://doi.org/10.1002/mgg3.1442.
Article PubMed PubMed Central Google Scholar
Cheng Y, Luo R, Wang K, Zhang M, Wang Z, Dong L, et al. Kidney disease is associated with in-hospital death of patients with COVID-19. Kidney Int. 2020;97(5):829–38. https://doi.org/10.1016/j.kint.2020.03.005.
Comments (0)